학술논문
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
Document Type
Article
Author
Source
In Parkinsonism and Related Disorders June 2021 87:25-31
Subject
Language
ISSN
1353-8020